<DOC>
	<DOCNO>NCT00747331</DOCNO>
	<brief_summary>Cardiopulmonary bypass ( CPB ) cardiac operation may accompany different pattern visceral underperfusion . This could result clinical pattern lactic acidosis severe case risk mesenteric infarction ( 0.2 % case ) . Renal function well may impair due low oxygen delivery , acute renal failure occur 1-2 % case . Fenoldopam mesilate selective splanchnic vasodilator use dose &lt; 0.1 mcg/kg/min . The experimental hypothesis randomize , control trial ( RCT ) use fenoldopam may determine good visceral perfusion CPB .</brief_summary>
	<brief_title>Fenoldopam Splanchnic Perfusion During Cardiopulmonary Bypass</brief_title>
	<detailed_description>Randomized placebo-controlled double blind study . Patients undergo complex cardiac operation randomly allocate study control group . All patient receive standard care Institution . Adequacy CPB perfusion assess use oxygen delivery calculation , lactate production , SvO2 .</detailed_description>
	<mesh_term>Fenoldopam</mesh_term>
	<criteria>Complex , combine cardiac operation Predicted CPB duration &gt; 90 minute Age &lt; 18 year No write inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Lactic acidosis</keyword>
	<keyword>Oxygen delivery</keyword>
	<keyword>Acute renal failure</keyword>
	<keyword>outcome</keyword>
	<keyword>cardiac</keyword>
	<keyword>surgery</keyword>
</DOC>